Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Pharmaceutical Companies in 2024
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2024, World Largest Pharmaceutical Companies by Market Cap in 2024.
  1. Baxter International

    World Rank (Jan-05-2024)
    929
    Market Cap (Jan-05-2024)
    19.598 Billion USD
    World Rank (Jul-30-2023)
    791
    Market Cap (Jul-30-2023)
    23.780 Billion USD
    World Rank (Dec-25-2022)
    667
    Market Cap (Dec-25-2022)
    25.292 Billion USD
    World Rank (Jan-07-2022)
    453
    Market Cap (Jan-07-2022)
    43.79 Billion USD
    Annual Revenue in USD
    15,113 Million USD
    Annual Operating Income in USD
    869 Million USD
    Annual Net Income in USD
    -2,433 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    BAXTER INTERNATIONAL develops Healthcare Products, Medical Devices with headquarters is in USA. Develops healthcare products related to kidney diseases and immunity disorders.

    BAXTER INTERNATIONAL PRODUCTS:

  2. BioMarin Pharmaceutical

    World Rank (Jan-05-2024)
    985
    Market Cap (Jan-05-2024)
    18.409 Billion USD
    World Rank (Jul-30-2023)
    1,112
    Market Cap (Jul-30-2023)
    16.444 Billion USD
    World Rank (Dec-25-2022)
    863
    Market Cap (Dec-25-2022)
    19.391 Billion USD
    World Rank (Jan-07-2022)
    1,308
    Market Cap (Jan-07-2022)
    15.47 Billion USD
    Annual Revenue in USD
    2,096 Million USD
    Annual Operating Income in USD
    41 Million USD
    Annual Net Income in USD
    141 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Biomarin Pharmaceutical is Pharmaceutical and Biotechnology Company with headquarters is in California, USA.

    It develops innovate therapies and life-threatening rare diseases and medical conditions.It consists of seven commercial products for the treatment of various diseases.

    As on 2022, Biomarin Pharmaceutical has 3,082 employees.

    Biomarin Pharmaceutical annual revenue generated for period ending Dec-2022 was 2,096 million USD.

  3. BeiGene Ltd.

    World Rank (Jan-05-2024)
    1,052
    Market Cap (Jan-05-2024)
    17.087 Billion USD
    World Rank (Jul-30-2023)
    812
    Market Cap (Jul-30-2023)
    23.146 Billion USD
    World Rank (Dec-25-2022)
    710
    Market Cap (Dec-25-2022)
    23.788 Billion USD
    World Rank (Jan-07-2022)
    898
    Market Cap (Jan-07-2022)
    23.27 Billion USD
    Annual Revenue in USD
    1,415 Million USD
    Annual Operating Income in USD
    -1,789 Million USD
    Annual Net Income in USD
    -2,003 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Bio Pharmaceutical Company with headquarters is in Cayman Islands.

  4. UCB SA

    World Rank (Jan-05-2024)
    1,055
    Market Cap (Jan-05-2024)
    16.926 Billion USD
    World Rank (Jul-30-2023)
    1,073
    Market Cap (Jul-30-2023)
    17.074 Billion USD
    World Rank (Dec-25-2022)
    1,081
    Market Cap (Dec-25-2022)
    15.163 Billion USD
    World Rank (Jan-07-2022)
    1,006
    Market Cap (Jan-07-2022)
    20.61 Billion USD
    Annual Revenue in USD
    6,083 Million USD
    Annual Operating Income in USD
    773 Million USD
    Annual Net Income in USD
    461 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    UCB is a global biopharmaceutical company focusing on creating value for people living with neurology and immunology conditions. Headquartered in Brussels, Belgium. As on 2019, UCB has Total revenue of 4.9 billion EUR and has more than 7,600 employees.
  5. Royalty Pharma PLC

    World Rank (Jan-05-2024)
    1,072
    Market Cap (Jan-05-2024)
    16.638 Billion USD
    World Rank (Jul-30-2023)
    1,273
    Market Cap (Jul-30-2023)
    13.997 Billion USD
    World Rank (Dec-25-2022)
    960
    Market Cap (Dec-25-2022)
    17.397 Billion USD
    World Rank (Jan-07-2022)
    1,178
    Market Cap (Jan-07-2022)
    17.29 Billion USD
    Annual Revenue in USD
    2,237 Million USD
    Annual Operating Income in USD
    922 Million USD
    Annual Net Income in USD
    42 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Royalty Pharma is the leader in acquiring Pharmaceutical company royalties across the life sciences industry. The headquarters is in USA.

    Royalty Pharma plc is a funder of biopharmaceutical industry.The company includes royalties on commercial products.

    It is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.

    As on 2019, Royalty Pharma has 35 employees.

  6. Tongwei

    World Rank (Jan-05-2024)
    1,147
    Market Cap (Jan-05-2024)
    15.526 Billion USD
    World Rank (Jul-30-2023)
    858
    Market Cap (Jul-30-2023)
    21.798 Billion USD
    World Rank (Dec-25-2022)
    692
    Market Cap (Dec-25-2022)
    24.480 Billion USD
    World Rank (Jan-07-2022)
    708
    Market Cap (Jan-07-2022)
    29.70 Billion USD
    Annual Revenue in USD
    19,925 Million USD
    Annual Operating Income in USD
    6,027 Million USD
    Annual Net Income in USD
    3,599 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    TONGWEI has business in agriculture related and animal feeds producing company. Headquarters is in China.

  7. PPD Inc.

    World Rank (Jan-05-2024)
    1,172
    World Rank (Jul-30-2023)
    1,172
    World Rank (Dec-25-2022)
    1,172
    World Rank (Jan-07-2022)
    1,172
    Market Cap (Jan-07-2022)
    17.40 Billion USD
    Annual Revenue in USD
    4,681 Million USD
    Annual Net Income in USD
    120 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    PPD is a global provider of Clinical Development and Laboratory Services company. PPD is a Global Contract Research Organization focused on Delivering Life-changing Therapies. The headquarters is in USA.

    Thermo Fisher Scientific acquired PPD Inc. for 17.4 billion USD in 2021.

    Facts About Company

    PPD annual revenue for year ending Dec-2020 was 4.7 billion USD. PPD has over 40,000 employees as on 2023.

  8. Incyte Corporation

    World Rank (Jan-05-2024)
    1,185
    Market Cap (Jan-05-2024)
    14.923 Billion USD
    World Rank (Jul-30-2023)
    1,265
    Market Cap (Jul-30-2023)
    14.075 Billion USD
    World Rank (Dec-25-2022)
    918
    Market Cap (Dec-25-2022)
    18.101 Billion USD
    World Rank (Jan-07-2022)
    1,253
    Market Cap (Jan-07-2022)
    16.17 Billion USD
    Annual Revenue in USD
    3,394 Million USD
    Annual Operating Income in USD
    591 Million USD
    Annual Net Income in USD
    340 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Incyte Corporation is a Bio-Pharmaceutical company with headquarters is in Delaware, USA.

    As on 2021, Incyte Corporation has 2,094 employees, 989 are in research and development, 187 in medical affairs, 638 in sales and marketing and 280 in operations support, finance and administrative positions.

    As on 2022, Incyte Corporation has 2,324 employees.

    Incyte Corporation annual revenue generated for period ending Dec-2022 was 3,394 million USD.

  9. Sandoz Group AG

    World Rank (Jan-05-2024)
    1,209
    Market Cap (Jan-05-2024)
    14.504 Billion USD
    Headquarters Country
    Company Profile

    Switzerland based pharmaceutical company. Headquarters is in Switzerland.

  10. Eisai

    World Rank (Jan-05-2024)
    1,230
    Market Cap (Jan-05-2024)
    14.345 Billion USD
    World Rank (Jul-30-2023)
    995
    Market Cap (Jul-30-2023)
    18.227 Billion USD
    World Rank (Dec-25-2022)
    881
    Market Cap (Dec-25-2022)
    18.732 Billion USD
    World Rank (Jan-07-2022)
    1,258
    Market Cap (Jan-07-2022)
    16.12 Billion USD
    Annual Revenue in USD
    5,273 Million USD
    Annual Operating Income in USD
    284 Million USD
    Annual Net Income in USD
    393 Million USD
    Annual Results for Period Ending
    Mar-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Eisai is Pharmaceutical and Healthcare Products company with headquarters is in Tokyo, Japan.

    Facts About Company

    For year ending March-2023, Eisai annual revenue was 744 billion JPY, annual operating income was 40 billion JPY and annual net income was 55.4 billion JPY.

    Eisai had 11,076 employees as on 2023.

    It had 15 Drug Discovery, Research and Development, and Clinical Research Sites and 9 Production sites.

Share

Ads